Percutaneous Treatment of Multivalvular Disease Including Refractory Tricuspid Regurgitation in a Frail Elderly Patient

经皮治疗体弱老年患者的多瓣膜疾病,包括难治性三尖瓣反流

阅读:1

Abstract

BACKGROUND: This clinical vignette highlights the feasibility of a comprehensive transcatheter strategy for managing advanced multivalvular heart disease in a frail elderly patient. CASE SUMMARY: A 79-year-old woman with prior surgical aortic valve replacement, chronic atrial fibrillation, and multiple comorbidities presented with worsening heart failure. Physical examination demonstrated anasarca with signs of left and right heart failure. An echocardiogram demonstrated severe stenosis of a prior bioprosthetic aortic valve, with a valve area of 0.64 cm(2), functional mitral regurgitation, and torrential tricuspid insufficiency. Stepwise management included percutaneous valve-in-valve transcatheter aortic valve replacement, edge-to-edge mitral repair, and transcatheter tricuspid valve placement, leading to marked clinical improvement and reversal of congestion. These interventions stabilized the patient's renal function and enhanced her overall functional status. DISCUSSION: This case underscores the potential role of transcatheter interventions in high-risk patients, indicating that advanced age and frailty, in addition to procedural success, critically influence long-term outcomes. TAKE-HOME MESSAGE: Frailty and associated comorbidities remain pivotal challenges and require diligent postprocedural follow-up, but they are not absolute contraindications for percutaneous treatment.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。